Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,084 public trials 6,466 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

NCT03459534

Conditions
Bone Marrow Diseases, CML - Philadelphia Chromosome, CML, Chronic Phase, +15 more
Locations
  • Territorial State Budgetary Institution Barnaul, Russia
  • Federal State Budgetary Institution of Science Kirov, Russia
  • Federal State Budgetary Institution Moscow, Russia
  • Hematology Centre based on City Clin. Hosp. n.a. S.P. Botkin Moscow, Russia
View all 18 locations
View Trial Details
Recruiting

A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma

NCT07493135

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beijing GoBroad Boren Hospital Beijing, China
  • The second affiliated hospital of Chongqing medical university Chongqing, China
  • Renji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China
  • Zhengzhou Yihe Hospital Zhengzhou, China
View Trial Details
Recruiting

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

NCT06156410

Conditions
Disease Attributes, Ewing Sarcoma, Neoplasms, +11 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Liposarcoma, +13 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 257 locations
View Trial Details
Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

NCT06465199

Conditions
Atypical Teratoid/Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +30 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 14 locations
View Trial Details

Related conditions